Despite the WHO declaring that COVID-19 was no longer a global emergency as of May 2023, there is still a significant unmet clinical need and global economic cost associated with currently circulating variants of SARS-CoV-2
Less common side effects include flushing, headache, or nausea
This activation reduces the inhibitory binding between Caveolin-1 and eNOS, allowing greater eNOS activation and nitric oxide productionwith laboratory studies showing BPC-157 at 1 g/ml increases NO production 1.35-fold compared to controls
Standard subcutaneous injection in the abdominal area is sufficient
For institutions exploring BPC-157 alongside other research peptides, our full peptide collection maintains the same synthesis and purity standards across every compound
The appropriate site depends on factors like age, muscle mass, and the type of medication administered